Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
NCT ID: NCT07151339
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-11-01
2030-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969
Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia
NCT01095939
Kidney Injury Biomarkers in Preeclampsia
NCT03217916
Cardiovascular Risk After Preeclampsia
NCT05277233
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Schleswig-Holstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura Katharina Sievers
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Schleswig- Holstein
Kiel, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D557/24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.